The availability of fetal fibronectin for the management of asymptomatic high-risk women in a preterm surveillance clinic: effect on utilisation of hospital resources

Abstract

BackgroundFetal fibronectin (fFN) testing is increasingly used to target women at risk of spontaneous preterm birth (sPTB) to determine corticosteroid administration, hospital admission and in utero transfer. Following its introduction...